New hope for dementia patients: 52-week trial targets psychosis symptoms
NCT ID NCT07095465
First seen Jan 11, 2026 · Last updated May 18, 2026 · Updated 21 times
Summary
This study tests a drug called ACP-204 for people with Lewy body dementia who experience psychosis (hallucinations or delusions). Over 52 weeks, researchers will monitor safety and side effects in 126 adults who previously completed an earlier phase of the trial. The goal is to see if long-term treatment can help control these distressing symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEWY BODY DEMENTIA PSYCHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Advanced Clinical Research Network, Corp
Miami, Florida, 33135, United States
-
Hawaii Pacific Neuroscience
Honolulu, Hawaii, 96817, United States
-
Health Synergy Clinical Research, LLC
West Palm Beach, Florida, 33407, United States
-
Homestead Associates in Research Inc
Miami, Florida, 33032, United States
-
Humanity Clinical Research, Corp
Aventura, Florida, 33180, United States
-
K2 Summit Research
Lady Lake, Florida, 32159, United States
-
MediClear Medical & Research Center, Inc.
Miami, Florida, 33165, United States
-
R and H Clinical Research
Stafford, Texas, 77477, United States
-
The Movement Disorder Clinic of Oklahoma
Tulsa, Oklahoma, 74136, United States
-
The Ohio State University, Energy Advancement and Innovation Center
Columbus, Ohio, 43210, United States
-
University of Kansas Medical Center Research Institute Inc.
Kansas City, Kansas, 66160, United States
-
Vestra Clinics s.r.o
Rychnov nad Kněžnou, 51601, Czechia
Conditions
Explore the condition pages connected to this study.